Ainos, Inc.
Business
Ainos, Inc. is a dual-platform company developing artificial intelligence-based scent digitization technology and immune therapeutics. The company's primary focus is commercializing AI Nose, an AI-powered electronic olfaction system that digitizes scent and volatile organic compound signals into machine-readable data for healthcare and industrial applications including semiconductor manufacturing and smart manufacturing. Secondary programs include VELDONA®, a low-dose oral interferon platform targeting rare autoimmune and infectious disease indications, and VELDONA® Pet supplements commercialized in Taiwan. The company operates through outsourced manufacturing partnerships and third-party commercial relationships, with research and development primarily based in Taiwan.
Summary from 10-K filed 2026-03-30
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenues | 124,157 | 20,729 | 122,112 | 4 | 594,563 | |
| Cost of revenues | −21,246 | −52,595 | −375,845 | −2 | −184,181 | |
| Gross profit (loss) | 102,911 | −31,866 | −253,733 | 1 | 410,382 | |
| Research and development expenses (including amounts for related party of $947,084 and $1,418,887 for the years ended December 31, 2025 and 2024, respectively) | 8 | 8 | 7 | 7 | 2 | |
| Selling, general and administrative expenses | 6 | 5 | 6 | 9 | 2 | |
| Total operating expenses | 14 | 14 | 13 | 15 | 4 | |
| Loss from operations | −14 | −14 | −13 | −14 | −4 | |
| Interest expense | −711,903 | −616,467 | −144,193 | — | — | |
| Issuance cost of senior secured convertible note measured at fair value | — | −308,336 | — | — | — | |
| Fair value change of senior secured convertible note | — | −275,624 | 94,207 | 0 | — | |
| Other income (expenses), net | −67,901 | 179,270 | — | 23,050 | −2,547 | |
| Total non-operating expenses, net | −779,804 | −1 | −563,353 | −30,478 | −21,236 | |
| Net loss before income taxes | −15 | −15 | −14 | −14 | −21,236 | |
| Provision for income taxes | 800 | 800 | 800 | 0 | — | |
| Net loss | −15 | −15 | −14 | −14 | −4 | |
| Net loss per common share - basic | −3.46 | −7.82 | −3.36 | — | — | |
| Net loss per common share - diluted | −3.46 | −7.82 | −3.36 | — | — | |
| Weighted-average shares used in computing net loss per common share-basic | 4 | 2 | 4 | — | — | |
| Weighted-average shares used in computing net loss per common share-diluted | 4 | 2 | 4 | — | — |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 417,353 | 4 | 2 | 2 | 2 | |
| Accounts receivable | 22 | 56 | 455 | 201,546 | 0 | |
| Inventory, net | 295,565 | 143,756 | 167,593 | 595,222 | 0 | |
| Other current assets | 425,859 | 301,077 | 419,521 | 195,787 | 466,198 | |
| Total current assets | 1 | 4 | 2 | 3 | 2 | |
| Intangible assets, net | 19 | 24 | 28 | 33 | 37 | |
| Property and equipment, net | 343,281 | 559,645 | 876,572 | 1 | 1 | |
| Other assets | 163,025 | 174,418 | 208,827 | 80,683 | 466,198 | |
| Total assets | 21 | 29 | 32 | 37 | 41 | |
| Contract liabilities (including amounts to related party of $350,000 and nil as of December 31, 2025 and 2024, respectively) | 350,000 | 106,329 | 112,555 | — | — | |
| Convertible notes payable (including amounts to related party of nil and $2,000,000 as of December 31, 2025 and 2024, respectively) | — | 3 | — | 376,526 | — | |
| Accrued expenses and other current liabilities | 728,683 | 848,615 | 1 | 1 | — | |
| Total current liabilities | 1 | 4 | 1 | 2 | 31 | |
| Convertible notes payable - noncurrent (including amounts to related party of $11,000,000 and $9,000,000 as of December 31, 2025 and 2024, respectively) | 11 | 9 | 3 | 0 | — | |
| Other long-term liabilities | 1 | 348,945 | 135,829 | 8,096 | — | |
| Total liabilities | 13 | 13 | 7 | 2 | 31 | |
| Commitments and contingencies | — | — | — | — | — | |
| Preferred stock, $0.01 par value; 50,000,000 shares authorized as of December 31, 2025 and 2024, respectively; none issued and outstanding | — | — | — | 0 | 0 | |
| Common stock, $0.01 par value; 300,000,000 shares authorized as of December 31, 2025 and 2024; 6,982,675 shares and 3,085,477 shares issued and 5,882,675 and 3,085,477 shares outstanding as of December 31, 2025 and 2024, respectively | 69,827 | 30,854 | 46,778 | 40,023 | 96,251 | |
| Treasury stock, at cost (1,160,000 and nil shares held as of December 31, 2025 and 2024, respectively) | −2 | — | — | — | — | |
| Additional paid-in capital | 77 | 69 | 63 | 59 | 20 | |
| Accumulated deficit | −68 | −53 | −38 | −24 | −10 | |
| Accumulated other comprehensive loss - translation adjustment | −249,291 | −409,529 | −270,473 | −201,653 | — | |
| Total stockholders equity | 8 | 16 | 24 | 35 | 10 | |
| Total liabilities and stockholders equity | 21 | 29 | 32 | 37 | 41 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 5 | 5 | 5 | 5 | 2 | |
| Share-based compensation expense | 2 | 4 | 1 | — | 160,978 | |
| Stock issued for special stock bonus | 3 | 88,996 | 2 | 0 | — | |
| Issuance cost of senior secured convertible note measured at fair value | — | 308,336 | — | — | — | |
| Issuance of common stock for consulting services | 225,000 | — | — | — | — | |
| Changes in fair value of senior secured convertible note | — | 275,624 | −94,207 | 0 | — | |
| Gain on disposal of property, plant and equipment | −1,096 | — | 286,777 | 0 | 2,223 | |
| Accounts receivable | 34 | 399 | 201,091 | −201,546 | 0 | |
| Inventory | −151,809 | 23,837 | 221,767 | −595,222 | 3,024 | |
| Other current assets | −123,085 | 118,444 | −223,734 | 270,411 | −415,054 | |
| Accrued expenses and other current and long-term liabilities | 1 | −105,559 | −9,327 | — | — | |
| Net cash used in operating activities | −5 | −6 | −5 | −3 | −1 | |
| Purchase of property and equipment | −34,561 | −21,331 | −92,984 | −633,823 | −143,792 | |
| Decrease (Increase) in refundable deposits and other assets | 32,338 | −103,961 | −8,541 | — | — | |
| Net cash used in investing activities | −2,223 | −125,292 | −101,525 | −630,178 | −180,517 | |
| Proceeds from convertible notes payable- noncurrent, related party | — | 9 | 2 | 800,000 | 3 | |
| Proceeds from senior secured convertible notes payable | — | 875,000 | 3 | 0 | — | |
| Proceeds from at-the-market offering, net of issuance costs | 2 | — | — | — | — | |
| Repayment of convertible notes payable | −1 | — | −390,000 | — | — | |
| Repayment of senior secured convertible notes payable | — | −1 | — | — | — | |
| Repayment of other notes payable, related party | — | −312,000 | — | — | — | |
| Payment of issuance cost of senior secured convertible note measured at fair value | — | −97,500 | −114,026 | 0 | — | |
| Fractional shares paid out in cash for the reverse stock split | −260 | — | — | — | — | |
| Net cash provided by financing activities | 1 | 8 | 5 | 4 | 3 | |
| Effect from foreign currency exchange | 132,893 | −84,896 | −95,214 | −78,021 | 5,375 | |
| Net (decrease) increase in cash and cash equivalents | −3 | 2 | 32,266 | 101,863 | 2 | |
| Cash paid for interest | 32 | 21,671 | 16,897 | 43,254 | 19,380 | |
| Cash paid for income taxes | 800 | 800 | 800 | — | — | |
| Issuance of common stock for consulting services | 225,000 | — | — | — | — | |
| Conversion of senior secured convertible notes to common stock | — | 2 | 254,237 | 0 | — | |
| Receivable from disposal of property, plant and equipment | 1,697 | — | — | — | — | |
| Issuance of common stock for exchanging subsidiary company shares | 2 | — | — | — | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Ainos, Inc.'s CIK number?
Ainos, Inc.'s SEC CIK number is 0001014763 (1014763). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Ainos, Inc.'s SEC filings?
All of Ainos, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Ainos, Inc. last report earnings?
Ainos, Inc. (AIMD) most recently filed an earnings 8-K with the SEC on May 13, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001493152-26-022751). This is Ainos, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Ainos, Inc.'s most recent earnings 8-K?
Ainos, Inc.'s latest earnings 8-K (Item 2.02) was filed May 13, 2026 under accession 0001493152-26-022751. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Ainos, Inc.'s latest earnings 8-K →
Look up any company's CIK number →